AAPL294.31+0.01 (+0.00%) ▲|ABBV235.75+0.99 (+0.42%) ▲|ABT91.40+0.87 (+0.96%) ▲|ACN130.94+3.93 (+3.09%) ▲|ADBE197.85+0.42 (+0.21%) ▲|AMAT572.52-13.36 (-2.28%) ▼|AMD508.48-11.38 (-2.19%) ▼|AMGN353.24+6.23 (+1.79%) ▲|AMT176.42-2.96 (-1.65%) ▼|AMZN237.06+2.95 (+1.26%) ▲|AVGO378.38-1.77 (-0.47%) ▼|AXP343.00+5.22 (+1.55%) ▲|BA221.07+4.36 (+2.01%) ▲|BAC57.77-0.15 (-0.25%) ▼|BKNG184.50+15.56 (+9.21%) ▲|BLK988.67-26.67 (-2.63%) ▼|BMY55.34-0.19 (-0.34%) ▼|BNY144.54-2.75 (-1.87%) ▼|BRK-B497.12+4.31 (+0.87%) ▲|C144.01-0.96 (-0.66%) ▼|CAT981.87-2.37 (-0.24%) ▼|CL92.71+1.28 (+1.39%) ▲|CMCSA22.74-0.06 (-0.26%) ▼|COF201.78+3.97 (+2.00%) ▲|COP107.01-2.96 (-2.69%) ▼|COST963.90+6.22 (+0.65%) ▲|CRM153.22-0.20 (-0.13%) ▼|CSCO119.21-1.94 (-1.60%) ▼|CVS101.33-0.24 (-0.24%) ▼|CVX171.84-4.15 (-2.36%) ▼|DE608.40+16.46 (+2.78%) ▲|DHR188.62+9.65 (+5.39%) ▲|DIS102.23-1.31 (-1.26%) ▼|DUK126.21+1.16 (+0.93%) ▲|EMR141.69-1.45 (-1.01%) ▼|FDX312.42-4.82 (-1.52%) ▼|GD346.49-3.85 (-1.10%) ▼|GE367.07+10.60 (+2.97%) ▲|GEV1,052.12+17.14 (+1.66%) ▲|GILD125.92+0.87 (+0.70%) ▲|GM79.56+0.61 (+0.77%) ▲|GOOG342.82-3.26 (-0.94%) ▼|GOOGL343.37-2.72 (-0.79%) ▼|GS1,076.97-17.47 (-1.60%) ▼|HD342.39+17.94 (+5.53%) ▲|HON227.43+5.06 (+2.28%) ▲|IBM263.09-1.85 (-0.70%) ▼|INTC129.50-2.79 (-2.11%) ▼|INTU266.54+8.49 (+3.29%) ▲|ISRG403.09-0.10 (-0.02%) ▼|JNJ240.69+1.61 (+0.67%) ▲|JPM333.46-0.68 (-0.20%) ▼|KO81.02+0.71 (+0.88%) ▲|LIN518.88+6.62 (+1.29%) ▲|LLY1,113.83+6.75 (+0.61%) ▲|LMT496.42-7.25 (-1.44%) ▼|LOW221.86+8.32 (+3.90%) ▲|LRCX364.09-7.24 (-1.95%) ▼|MA496.94+8.87 (+1.82%) ▲|MCD275.42+3.76 (+1.38%) ▲|MDLZ62.16+1.10 (+1.80%) ▲|MDT80.77+0.14 (+0.17%) ▲|META559.66-2.54 (-0.45%) ▼|MMM166.39+4.55 (+2.81%) ▲|MO72.22+0.61 (+0.85%) ▲|MRK121.26+1.66 (+1.39%) ▲|MS220.78-5.26 (-2.32%) ▼|MSFT368.77-5.17 (-1.38%) ▼|MU1,015.70-36.07 (-3.43%) ▼|NEE87.43+1.00 (+1.15%) ▲|NFLX72.36-0.46 (-0.63%) ▼|NKE41.75-0.63 (-1.48%) ▼|NOW93.85-2.10 (-2.18%) ▼|NVDA197.51-2.50 (-1.25%) ▼|ORCL156.11-9.05 (-5.48%) ▼|PEP142.99+0.94 (+0.66%) ▲|PFE24.15-0.58 (-2.33%) ▼|PG152.77+1.91 (+1.27%) ▲|PLTR113.37-3.33 (-2.85%) ▼|PM179.21+0.52 (+0.29%) ▲|QCOM193.45-10.69 (-5.23%) ▼|RTX186.71+0.32 (+0.17%) ▲|SBUX104.37+3.32 (+3.29%) ▲|SCHW91.45-1.73 (-1.85%) ▼|SO95.46+0.53 (+0.55%) ▲|SPG222.29+5.55 (+2.56%) ▲|T22.47-0.35 (-1.51%) ▼|TMO490.94+21.59 (+4.60%) ▲|TMUS183.00-1.57 (-0.85%) ▼|TSLA374.75-6.86 (-1.80%) ▼|TXN303.03-1.33 (-0.44%) ▼|UBER74.13+4.46 (+6.40%) ▲|UNH403.76-5.49 (-1.34%) ▼|UNP260.33+1.72 (+0.67%) ▲|UPS105.39-0.44 (-0.42%) ▼|USB60.22+0.17 (+0.27%) ▲|V333.23+4.75 (+1.45%) ▲|VZ45.81-0.92 (-1.97%) ▼|WFC84.40+0.27 (+0.32%) ▲|WMT119.72+0.30 (+0.25%) ▲|XOM136.30-3.43 (-2.45%) ▼|AAPL294.31+0.01 (+0.00%) ▲|ABBV235.75+0.99 (+0.42%) ▲|ABT91.40+0.87 (+0.96%) ▲|ACN130.94+3.93 (+3.09%) ▲|ADBE197.85+0.42 (+0.21%) ▲|AMAT572.52-13.36 (-2.28%) ▼|AMD508.48-11.38 (-2.19%) ▼|AMGN353.24+6.23 (+1.79%) ▲|AMT176.42-2.96 (-1.65%) ▼|AMZN237.06+2.95 (+1.26%) ▲|AVGO378.38-1.77 (-0.47%) ▼|AXP343.00+5.22 (+1.55%) ▲|BA221.07+4.36 (+2.01%) ▲|BAC57.77-0.15 (-0.25%) ▼|BKNG184.50+15.56 (+9.21%) ▲|BLK988.67-26.67 (-2.63%) ▼|BMY55.34-0.19 (-0.34%) ▼|BNY144.54-2.75 (-1.87%) ▼|BRK-B497.12+4.31 (+0.87%) ▲|C144.01-0.96 (-0.66%) ▼|CAT981.87-2.37 (-0.24%) ▼|CL92.71+1.28 (+1.39%) ▲|CMCSA22.74-0.06 (-0.26%) ▼|COF201.78+3.97 (+2.00%) ▲|COP107.01-2.96 (-2.69%) ▼|COST963.90+6.22 (+0.65%) ▲|CRM153.22-0.20 (-0.13%) ▼|CSCO119.21-1.94 (-1.60%) ▼|CVS101.33-0.24 (-0.24%) ▼|CVX171.84-4.15 (-2.36%) ▼|DE608.40+16.46 (+2.78%) ▲|DHR188.62+9.65 (+5.39%) ▲|DIS102.23-1.31 (-1.26%) ▼|DUK126.21+1.16 (+0.93%) ▲|EMR141.69-1.45 (-1.01%) ▼|FDX312.42-4.82 (-1.52%) ▼|GD346.49-3.85 (-1.10%) ▼|GE367.07+10.60 (+2.97%) ▲|GEV1,052.12+17.14 (+1.66%) ▲|GILD125.92+0.87 (+0.70%) ▲|GM79.56+0.61 (+0.77%) ▲|GOOG342.82-3.26 (-0.94%) ▼|GOOGL343.37-2.72 (-0.79%) ▼|GS1,076.97-17.47 (-1.60%) ▼|HD342.39+17.94 (+5.53%) ▲|HON227.43+5.06 (+2.28%) ▲|IBM263.09-1.85 (-0.70%) ▼|INTC129.50-2.79 (-2.11%) ▼|INTU266.54+8.49 (+3.29%) ▲|ISRG403.09-0.10 (-0.02%) ▼|JNJ240.69+1.61 (+0.67%) ▲|JPM333.46-0.68 (-0.20%) ▼|KO81.02+0.71 (+0.88%) ▲|LIN518.88+6.62 (+1.29%) ▲|LLY1,113.83+6.75 (+0.61%) ▲|LMT496.42-7.25 (-1.44%) ▼|LOW221.86+8.32 (+3.90%) ▲|LRCX364.09-7.24 (-1.95%) ▼|MA496.94+8.87 (+1.82%) ▲|MCD275.42+3.76 (+1.38%) ▲|MDLZ62.16+1.10 (+1.80%) ▲|MDT80.77+0.14 (+0.17%) ▲|META559.66-2.54 (-0.45%) ▼|MMM166.39+4.55 (+2.81%) ▲|MO72.22+0.61 (+0.85%) ▲|MRK121.26+1.66 (+1.39%) ▲|MS220.78-5.26 (-2.32%) ▼|MSFT368.77-5.17 (-1.38%) ▼|MU1,015.70-36.07 (-3.43%) ▼|NEE87.43+1.00 (+1.15%) ▲|NFLX72.36-0.46 (-0.63%) ▼|NKE41.75-0.63 (-1.48%) ▼|NOW93.85-2.10 (-2.18%) ▼|NVDA197.51-2.50 (-1.25%) ▼|ORCL156.11-9.05 (-5.48%) ▼|PEP142.99+0.94 (+0.66%) ▲|PFE24.15-0.58 (-2.33%) ▼|PG152.77+1.91 (+1.27%) ▲|PLTR113.37-3.33 (-2.85%) ▼|PM179.21+0.52 (+0.29%) ▲|QCOM193.45-10.69 (-5.23%) ▼|RTX186.71+0.32 (+0.17%) ▲|SBUX104.37+3.32 (+3.29%) ▲|SCHW91.45-1.73 (-1.85%) ▼|SO95.46+0.53 (+0.55%) ▲|SPG222.29+5.55 (+2.56%) ▲|T22.47-0.35 (-1.51%) ▼|TMO490.94+21.59 (+4.60%) ▲|TMUS183.00-1.57 (-0.85%) ▼|TSLA374.75-6.86 (-1.80%) ▼|TXN303.03-1.33 (-0.44%) ▼|UBER74.13+4.46 (+6.40%) ▲|UNH403.76-5.49 (-1.34%) ▼|UNP260.33+1.72 (+0.67%) ▲|UPS105.39-0.44 (-0.42%) ▼|USB60.22+0.17 (+0.27%) ▲|V333.23+4.75 (+1.45%) ▲|VZ45.81-0.92 (-1.97%) ▼|WFC84.40+0.27 (+0.32%) ▲|WMT119.72+0.30 (+0.25%) ▲|XOM136.30-3.43 (-2.45%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: light

newssourceFORcompanyinformationcontent1marketreleases

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

AMSTERDAM, June 23, 2025 /CNW/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President...

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development,...

Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 22, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development...

ThinkCareBelieve: Week 22 of America’s Rise to Greatness under President Trump’s Leadership

Washington, DC, June 21, 2025 (GLOBE NEWSWIRE) --

Link to ThinkCareBelieve's Article:  https://thinkcarebelieve.blog/2025/06/21/week-22-of-americas-rise-to-greatness-under-president-trumps-leadership/

Foothill Gold Line Dedicates Four New Metro A Line Stations From Glendora to Pomona

Hundreds of community members, elected officials, higher education and transportation officials celebrated the new stations across four ceremonies in June 2025 MONROVIA, Calif., June 21,...

Nixol Capsules Launch in the UK: A Natural Path to Weight Management and Metabolic Support

Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients. 
Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients.

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

ATN Night Vision Scopes Revolutionize Late-Night Hog Hunting for Serious Hunters

DORAL, Fla., June 21, 2025 (GLOBE NEWSWIRE) -- Wild hog hunting after dark presents a unique challenge even for the most seasoned sportsmen. Nocturnal and highly elusive, feral hogs demand precision, stealth, and top-tier equipment. That’s why hunters nationwide are turning to ATN, a global leader in digital and thermal optics, to gain the upper hand during late-night hunts.

Unplugged Performance to Showcase Tesla Builds at Electrify Expo – North America’s Largest EV Festival

Unplugged Performance to showcase 4 upgraded Teslas at Electrify Expo LA, highlighting track, off-road, and street builds.

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously announced acquisition (the “Acquisition”) by BioMarin Pharmaceutical Inc. (“BioMarin”).

Minister Guilbeault defends Canada’s cultural sovereignty in the digital age and calls for international cooperation during UNESCO conference

As UNESCO celebrates the 20th anniversary of the Convention on the Protection and Promotion of the Diversity of Cultural Expressions, the Government of Canada...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLight

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers